Hai Gang Chen
Director/Board Member chez SINOMAB BIOSCIENCE LIMITED
Profil
Hai Gang Chen is currently a Non-Executive Director at Sinomab Bioscience Ltd., a Director at Bellen Chemistry Co., Ltd., a Director at Yatra Pharmaceutical Technology (Shanghai) Co., Ltd., an Investment Director at Shanghai Yueyi Investment Center, a Director at Shanghai Weishen Pharmaceutical Co., Ltd., a Co-General Partner at Shanghai Xingze Xinghe Investment Management Center, and a Member-Supervisory Board at Suzhou Sinovent Pharmaceutical Technology Co. Ltd.
Previously, he worked as a Senior Manager at CITIC Securities Co., Ltd.
from 2010 to 2011 and as an Analyst at China International Capital Corp.
Ltd.
(Broker).
He holds a doctorate degree from Peking Union Medical College, conferred in 2009.
Postes actifs de Hai Gang Chen
| Sociétés | Poste | Début |
|---|---|---|
| SINOMAB BIOSCIENCE LIMITED | Director/Board Member | 01/08/2017 |
| Shanghai Yueyi Investment Center | Chief Investment Officer | - |
| Shanghai Xingze Xinghe Investment Management Center | Corporate Officer/Principal | 01/09/2016 |
Suzhou Sinovent Pharmaceutical Technology Co. Ltd.
 Suzhou Sinovent Pharmaceutical Technology Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Sinovent Pharmaceutical Technology Co. Ltd. is a private company that focuses on researching, developing, producing, and commercializing therapeutic drugs. The company is based in Suzhou, China. | Director/Board Member | - |
Shanghai Weishen Pharmaceutical Co., Ltd.
 Shanghai Weishen Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Shanghai Weishen Pharmaceutical Co., Ltd. is a company founded in 2019 that specializes in the research, development, production, sale, and service of pharmaceutical machinery. The company is based in Shanghai, China. The Chinese company focuses on scientific and technological innovation to serve the pharmaceutical industry with advanced technology. The company has a professional installation team with a minimum of 6 years of experience, possessing strong practical hands-on problem-solving capabilities. The company aims to improve the production standard and maximize investment benefits through effective training. | Director/Board Member | - |
Bellen Chemistry Co., Ltd.
 Bellen Chemistry Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Bellen Chemistry Co., Ltd. provides contract chemistry services. It offers chemical synthesis contract development and manufacturing organization (CDMO) services, chemical synthesis contract research organization (CRO) services, and drug molecular building blocks. The company was founded by Bo Liu, Li Xin Xing, Jian Hua Ren, Jian Xun Liu, and Yong Jun Jiang on January 28, 2010 and is headquartered in Beijing, China. | Director/Board Member | 01/01/2019 |
Yatra Pharmaceutical Technology (Shanghai) Co., Ltd.
 Yatra Pharmaceutical Technology (Shanghai) Co., Ltd. BiotechnologyHealth Technology Part of Hepagene Therapeutics, Inc., Yatra Pharmaceutical Technology (Shanghai) Co., Ltd. is a Chinese company that engages in research and development of new drugs. The private company is based in Shanghai, China. The company was founded in 2016 by Xiao Dong Xu. | Director/Board Member | - |
Anciens postes connus de Hai Gang Chen
| Sociétés | Poste | Fin |
|---|---|---|
| CITIC SECURITIES COMPANY LIMITED | Corporate Officer/Principal | 01/04/2011 |
China International Capital Corp. Ltd. (Broker)
 China International Capital Corp. Ltd. (Broker) Investment Banks/BrokersFinance China International Capital Corp. Ltd. (Broker) (CICC) is the brokerage division of China International Capital Corp. Ltd. which was established in 1995 as a strategic partnership between Chinese and international financial institutions and corporations. Headquartered in Beijing, CICC was the first joint venture investment bank in China. The firm's core business departments were investment banking, capital markets, sales & trading, research, fixed-income and asset management. CICC offers a range of brokerage services to international and domestic institutional and individual investors. In 2007 the firm set up a wholly-owned subsidiary specializing in private equity investments and focusing on buyout opportunities within China. | Analyst-Equity | - |
Formation de Hai Gang Chen
| Peking Union Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CITIC SECURITIES COMPANY LIMITED | Finance |
| SINOMAB BIOSCIENCE LIMITED | Health Technology |
| Entreprise privées | 7 |
|---|---|
China International Capital Corp. Ltd. (Broker)
China International Capital Corp. Ltd. (Broker) Investment Banks/BrokersFinance China International Capital Corp. Ltd. (Broker) (CICC) is the brokerage division of China International Capital Corp. Ltd. which was established in 1995 as a strategic partnership between Chinese and international financial institutions and corporations. Headquartered in Beijing, CICC was the first joint venture investment bank in China. The firm's core business departments were investment banking, capital markets, sales & trading, research, fixed-income and asset management. CICC offers a range of brokerage services to international and domestic institutional and individual investors. In 2007 the firm set up a wholly-owned subsidiary specializing in private equity investments and focusing on buyout opportunities within China. | Finance |
Bellen Chemistry Co., Ltd.
Bellen Chemistry Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Bellen Chemistry Co., Ltd. provides contract chemistry services. It offers chemical synthesis contract development and manufacturing organization (CDMO) services, chemical synthesis contract research organization (CRO) services, and drug molecular building blocks. The company was founded by Bo Liu, Li Xin Xing, Jian Hua Ren, Jian Xun Liu, and Yong Jun Jiang on January 28, 2010 and is headquartered in Beijing, China. | Commercial Services |
Yatra Pharmaceutical Technology (Shanghai) Co., Ltd.
Yatra Pharmaceutical Technology (Shanghai) Co., Ltd. BiotechnologyHealth Technology Part of Hepagene Therapeutics, Inc., Yatra Pharmaceutical Technology (Shanghai) Co., Ltd. is a Chinese company that engages in research and development of new drugs. The private company is based in Shanghai, China. The company was founded in 2016 by Xiao Dong Xu. | Health Technology |
| Shanghai Yueyi Investment Center | |
| Shanghai Xingze Xinghe Investment Management Center | |
Suzhou Sinovent Pharmaceutical Technology Co. Ltd.
Suzhou Sinovent Pharmaceutical Technology Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Suzhou Sinovent Pharmaceutical Technology Co. Ltd. is a private company that focuses on researching, developing, producing, and commercializing therapeutic drugs. The company is based in Suzhou, China. | Commercial Services |
Shanghai Weishen Pharmaceutical Co., Ltd.
Shanghai Weishen Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Shanghai Weishen Pharmaceutical Co., Ltd. is a company founded in 2019 that specializes in the research, development, production, sale, and service of pharmaceutical machinery. The company is based in Shanghai, China. The Chinese company focuses on scientific and technological innovation to serve the pharmaceutical industry with advanced technology. The company has a professional installation team with a minimum of 6 years of experience, possessing strong practical hands-on problem-solving capabilities. The company aims to improve the production standard and maximize investment benefits through effective training. | Health Technology |
